Given that ZEB1 is a key transcription factor of SCG2, we hypothesize that the upregulation of ZEB1 may result in the upregulation of SCG2, thereby indirectly influencing the pathophysiological process of CAVD. The gene discussed is ZEB1; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.